A new model ELISA, based on two monoclonal antibodies, for quantification of fatty acid synthase

Journal of Immunoassay and Immunochemistry

Volumn 23, Issue 3, 2002, Pages 279-292

  Wang, Young Y ^a   Kuhajda, Francis P ^a   Cheng, Paul ^b   Chee, Wey Yeeng ^b   Li, Tianwei ^b   Helzlsouer, Kathy J ^c   Sokoll, Lori J ^a   Chan, Daniel W ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b Johns Hopkins Singapore   (Singapore)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; FATTY ACID SYNTHASE; MONOCLONAL ANTIBODY; DIAGNOSTIC AGENT; TUMOR MARKER;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; ENZYME ASSAY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; QUANTITATIVE ASSAY; ADULT; BLOOD; BREAST TUMOR; CASE CONTROL STUDY; CELL CULTURE; COMPARATIVE STUDY; ENZYMOLOGY; FEMALE; IMMUNOLOGY; MALE; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARD; VALIDATION STUDY;

ADULT; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACID SYNTHETASE COMPLEX; FEMALE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0036037550     PISSN: 15321819     EISSN: None     Source Type: Journal    
DOI: 10.1081/IAS-120013027     Document Type: Article

References (19)

1. Expression of Fatty Acid Synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients
2. Fatty Acid Synthase (FAS) predictive strength in poorly differentiated early breast carcinomas
3. Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma
4. The prognostic value of oncogenic antigen 519 (OA-519) expression and proliferative activity detected by antibody MIB-1 in node-negative breast cancer
5. Fatty Acid Synthesis: A potential selective target for antineoplastic therapy
6. Fatty Acid Synthase expression in Japanese breast carcinoma patients
7. Elevated expression of Fatty Acid Synthase and fatty acid synthetic activity in colorectal neoplasia
8. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa
9. Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer
10. OA-519 (Fatty Acid Synthase) as an independent predictor of pathological stage in adenocarcinoma of the prostate
11. Selective activation of the fatty acid synthesis pathway in human prostate cancer
12. Increased expression of Fatty Acid Synthase (OA-519) in ovarian neoplasms predicts shorter survival
13. Fatty Acid Synthase expression is increased in neoplastic lesions of the oral tongue
14. Fatty Acid Synthase is highly expressed in aggressive thyroid tumors
15. The Expression of Fatty Acid Synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung
16. Fatty Acid Synthase expression in endometrial carcinoma: Correlation with cell proliferation and hormone receptors
17. Increased Fatty Acid Synthase is a therapeutic target in mesothelioma
18. Two-site ELISA for the quantitative determination of Fatty Acid Synthase
19. Fatty Acid Synthase (FAS) expression in human breast cancer cell culture supernatants and in breast cancer Patients